Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy
The present study investigated the effect of coenzyme Q10 on the survival rate of patients with cardiomyopathy. To this end, 137 cardiomyopathy patients were given coenzyme Q10 supplements over a period of 4 years. 43 patients were at an advanced stage of heart failure, with a pumping capacity (ejection fraction) of less than 40% and 25% on average. Coenzyme Q10 treatment improved the average ejection fraction from 25 to 42%, indicating a highly significant improvement of the cardiac performance. It was found that Q10 administration caused a significant increase in survival rate: After 3 years, 3 of 4 patients in this group were still alive. In the group without CoQ10 administration, however, only 1 patient of 4 had survived 3 years. The authors concluded that administration of coenzyme Q10 has a significant life-prolonging effect in patients with heart failure. Further details can be found in the study.
The heart is the “motor” of our body, contracting about 80,000 times a day to pump the blood through our circulatory system. It is the mechanically the most active organ of our body. The actual “work” is performed by billions of muscle cells that contract at the same time to form the heartbeat. And just like in a car, the biological motor “heart” needs energy to function properly. Micronutrients are the most important carriers of biological energy for an optimum contraction of the heart muscle cells. A long-term dietary deficiency of micronutrients leads to an insufficient contraction of the heart muscle cells, to a suboptimal pumping function of the heart and eventually to heart failure (cardiomyopathy). Typical heart failure symptoms include shortness of breath, edema and chronic fatigue, making everyday activities such as house cleaning, walking or going to the supermarket very difficult.
Langsjoen PH, Folkers K, Lyson K, Muratsu K, Lyson T, Langsjoen P. Pronounced increase of survival of patients with cardiomyopathy when treated with coenzyme Q10 and conventional therapy. Int J Tissue React. 1990;12(3):163-8.